InfuSystems Holdings, Inc.

INFU Healthcare Medical Devices

InfuSystems Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $143.4 million, up 6.36% from fiscal 2024. In the quarter to June 2026, revenue grew 2.59%, EPS grew 33.3%, free cash flow fell 66.5% and total debt fell 22.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

13.33 0.59 −4.24%
Market cap
$277.2M
P/E
31.7×
Fwd P/E
21.7×
Dividend yield
—
F-score
8/9
Altman Z
3.74
Beneish M
−3.30
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

9.95% 11.54% 13.89% 15.03%
Piotroski F-Score
8 8 8 9
ROA
5.41% 6.49% 7.80% 8.61%
ROIC
8.96% 10.10% 10.56% 10.55%
Return on Tangible Assets
26.94% 33.96% 34.79% 32.89%
Average Days of Receivables
62.90 58.28 61.46 69.28
Free Cash Flow per Share
0.92 0.92 0.97 0.75
Free Cash Flow
18.76 19.03 19.62 15.14
Other line items

Show all line items

Columns are period end dates